Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Curtis Jacquot dba Pacific BioLogic Co.
WARNING LETTER
•Curtis Jacquot dba Pacific BioLogic Co.•June 29, 2023

Curtis Jacquot dba Pacific BioLogic Co. – FDA Warning Letter, Jun 29, 2023

Record Details

The FDA inspected Pacific Biologic's facility from June 1-29, 2023, revealing significant violations of CGMP for dietary supplements (21 CFR Part 111). Additionally, a review of product labels and websites (www.pacificbiologic.com, www.balanceandharmony.com) in July 2023 found that several products (ArteClear Circulation 2, Headache Release, Natura-Mune – 2, Pain Release, Attack 2) are unapproved new drugs due to disease treatment claims, and misbranded drugs lacking adequate directions for use.

Key violations include: - **Unapproved New Drugs**: Products marketed with claims for disease cure, mitigation, treatment, or prevention (e.g., "natural relief for headaches and migraines," "inhibit bacterial, viral, and tumor growth") are considered new drugs requiring FDA approval, which they lack. This is a repeat observation from a 2014 Warning Letter and 2015 Regulatory Meeting. - **Misbranded Drugs**: Products like ArteClear Circulation 2, Natura-Mune – 2, and Attack 2 are misbranded because they are intended for conditions not amenable to self-diagnosis or treatment, thus lacking adequate directions for layperson use. - **Adulterated Dietary Supplements (CGMP Violations)**: - Failure to establish required specifications for components, labels, packaging, and finished products (e

Company
Curtis Jacquot dba Pacific BioLogic Co.
Inspection date
June 29, 2023
Product type
Food
Office
Division of Human and Animal Food Operations - West V
People
  • Darla R. Bracy
  • Sergio Chavez ( Assistant Deputy Chief)
  • Elodie X. Tong-lin
View Company Profile

ID · 1d6e2dc6-b09e-4f69-a35a-dac792f027f6

Violation Codes10
21 U.S.C. 34321 CFR 11121 CFR 101.3621 U.S.C. 342(g)(1)21 CFR 111.7521 CFR 111.21021 CFR 111.205(a)21 CFR 101.9(b)21 CFR 101.36(b)(2)(i)21 CFR 101.36(c)(2)

Full citation text and observation details available on the Dashboard.

Other documents for Curtis Jacquot dba Pacific BioLogic Co.
  • 483 - 2018-01-31January 31, 2018

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Curtis Jacquot dba Pacific BioLogic Co.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.